Bone-marrow transplantation in non-malignant disease

The Lancet

Volumn 374, Issue 9693, 2009, Pages 856-858

  Wynn, Robert F ^a   Boelens, Jaap Jan ^b  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INBORN ERROR OF METABOLISM; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RISK FACTOR; RISK REDUCTION; SICKLE CELL ANEMIA; THALASSEMIA;

EID: 69949096466     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61070-9     Document Type: Note

References (14)

1. Wynn R.F., Wraith J.E., Mercer J., et al. Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy. J Pediatr 154 (2009) 609-611
2. Brennan B.M., and Shalet S.M. Endocrine late effects after bone marrow transplant. Br J Haematol 118 (2002) 58-66
3. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110 (2007) 4576-4583
4. Eapen M., Rubinstein P., Zhang M.J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369 (2007) 1947-1954
5. Sivaprakasam P., Carr T.F., Coussons M., et al. Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention. J Pediatr Hematol Oncol 29 (2007) 81-85
6. Greenfield H.M., Gharib M.I., Turner A.J., et al. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?. Pediatric Blood Cancer 47 (2006) 200-205
7. Bartelink I.H., Bredius R.G., Belitser S.V., et al. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation. Biol Blood Marrow Transplant 15 (2009) 231-241
8. Niederwieser D., Lange T., Cross M., Basara N., and Al-Ali H. Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML. Best Pract Res Clin Haematol 19 (2006) 825-838
9. Shapira M.Y., Resnick I.B., Bitan M., et al. Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients. Bone Marrow Transplant 34 (2004) 155-159
10. Straathof K.C., Rao K., Eyrich M., et al. Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study. Lancet (2009) 10.1016/S0140-6736(09)60945-4 published online Sept 2.
11. Elter T., Vehreschild J.J., Gribben J., Cornely O.A., Engert A., and Hallek M. Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab. Ann Hematol 88 (2009) 121-132
12. Platt O.S., Brambilla D.J., Rosse W.F., et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 330 (1994) 1639-1644
13. Borgna-Pignatti C., Rugolotto S., De Stefano P., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89 (2004) 1187-1193
14. Vassiliou G., Amrolia P., and Roberts I.A. Allogeneic transplantation for haemoglobinopathies. Best Pract Res Clin Haematol 14 (2001) 807-822